Literature DB >> 8111460

Urinary N-acetyl-beta-D-glucosaminidase activity in workers exposed to inorganic lead.

K S Chia1, A Mutti, C Tan, H Y Ong, J Jeyaratnam, C N Ong, E Lee.   

Abstract

Urinary N-acetyl-beta-D-glucosaminidase (NAG) had been shown to be a useful early marker of renal injury. In workers exposed to lead it seems to be the only early marker but the dose response and dose effect relations are weak. Furthermore, the significance and underlying mechanism of increased urinary NAG activity is far from clear. By studying the isoenzyme profiles of urinary NAG, the significance and underlying mechanism may be further clarified. The heat labile (NAG-A) and heat stable (NAG-B) isoenzyme profiles of 128 workers exposed to lead from a lead stabiliser factory were analysed. NAG activity was expressed as total NAG, NAG-A, and NAG-B activity as well as ratios (NAG-B/total NAG and NAG-B/NAG-A). Exposure indices included the recent concentration of blood lead (BPb), a cumulative blood lead index (TBPb), and the recent change in concentration of blood lead (CBPb). The NAG indices correlated best with CBPb. Nearly 50% of the variation in NAG-B activity could be explained by the combination of all three exposure indices but only the CBPb was highly significant. When these exposure indices were entered separately into the regression equation, CBPb accounted for 36.3% of the variation in NAG-B activity, 5.7% was accounted for by TBPb and 2.7% by BPb. There was also no dose-effect or dose-response relation between the NAG variables and BPb or TBPb groups. With CBPb, there were dose-effect and dose-response relations. With CBPb, there was an increase in NAG variables in the group with more than 25% increase in blood lead over the past six months. The increase in NAG activity in this study is likely to be due to a recent increase in concentration of blood lead and hence presumably a recent rise in renal burden of inorganic lead. This suggests that the increase in urinary NAG activity is a form of acute response to a sharp increase in renal burden of lead, rather than to a cumulative dose. Heat stable NAG is part of the lysosomal membrane and is present in the urine when there is breakdown of lysosomes. Our data therefore contradict suggestions that the increase in urinary NAG activity is due to exocytosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8111460      PMCID: PMC1127917          DOI: 10.1136/oem.51.2.125

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  17 in total

Review 1.  Toxicity of lead at low dose.

Authors:  P J Landrigan
Journal:  Br J Ind Med       Date:  1989-09

2.  The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase by patients with renal disease.

Authors:  N Dance; R G Price; W R Cattell; J Lansdell; B Richards
Journal:  Clin Chim Acta       Date:  1970-01       Impact factor: 3.786

3.  Beta-galactosidase, beta-glucosidase and N-acetyl-beta-glucosaminidase in human kidney.

Authors:  N Dance; R G Price; D Robinson; J L Stirling
Journal:  Clin Chim Acta       Date:  1969-05       Impact factor: 3.786

Review 4.  Urinary enzymes, nephrotoxicity and renal disease.

Authors:  R G Price
Journal:  Toxicology       Date:  1982       Impact factor: 4.221

5.  Cadmium, NAG activity, and beta 2-microglobulin in the urine of cadmium pigment workers.

Authors:  A Bernard; R Lauwerys
Journal:  Br J Ind Med       Date:  1989-09

6.  Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate.

Authors:  A Noto; Y Ogawa; S Mori; M Yoshioka; T Kitakaze; T Hori; M Nakamura; T Miyake
Journal:  Clin Chem       Date:  1983-10       Impact factor: 8.327

7.  Urinary N-acetyl-beta-D-glucosaminidase (NAG) isoenzyme profiles: a tool for evaluating nephrotoxicity of aminoglycosides and cephalosporins.

Authors:  R Gibey; J L Dupond; J C Henry
Journal:  Clin Chim Acta       Date:  1984-02-14       Impact factor: 3.786

8.  Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals.

Authors:  B R Meyer; A Fischbein; K Rosenman; Y Lerman; D E Drayer; M M Reidenberg
Journal:  Am J Med       Date:  1984-06       Impact factor: 4.965

9.  The use of urinary N-acetyl-beta-glucosaminidase in human renal toxicology. I. Partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidney.

Authors:  T D Lockwood; H B Bosmann
Journal:  Toxicol Appl Pharmacol       Date:  1979-06-30       Impact factor: 4.219

10.  Presence of serum and tissue forms of N-acetyl-beta-glucosaminidase in urine from patients with renal disease.

Authors:  B G Ellis; S M Tucker; A E Thompson; R G Price
Journal:  Clin Chim Acta       Date:  1975-10-15       Impact factor: 3.786

View more
  9 in total

Review 1.  Biological monitoring: state of the art.

Authors:  P Hoet; V Haufroid
Journal:  Occup Environ Med       Date:  1997-06       Impact factor: 4.402

2.  Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase.

Authors:  Ryan M Franke; Ashley M Kosloske; Cynthia S Lancaster; Kelly K Filipski; Chaoxin Hu; Oliver Zolk; Ron H Mathijssen; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2010-07-02       Impact factor: 12.531

3.  Association of renal function and delta-aminolevulinic acid dehydratase polymorphism among Vietnamese and Singapore workers exposed to inorganic lead.

Authors:  S-E Chia; H J Zhou; E Yap; M T Tham; N-V Dong; N T Hong Tu; K-S Chia
Journal:  Occup Environ Med       Date:  2006-03       Impact factor: 4.402

4.  Association between NAG-B and cadmium in urine with no evidence of a threshold.

Authors:  A Bernard; N Thielemans; H Roels; R Lauwerys
Journal:  Occup Environ Med       Date:  1995-03       Impact factor: 4.402

5.  Lead absorption and renal dysfunction in a South African battery factory.

Authors:  R Ehrlich; T Robins; E Jordaan; S Miller; S Mbuli; P Selby; S Wynchank; A Cantrell; M De Broe; P D'Haese; A Todd; P Landrigan
Journal:  Occup Environ Med       Date:  1998-07       Impact factor: 4.402

6.  Biological monitoring of kidney function among workers occupationally exposed to trichloroethylene.

Authors:  T Green; J Dow; C N Ong; V Ng; H Y Ong; Z X Zhuang; X F Yang; L Bloemen
Journal:  Occup Environ Med       Date:  2004-04       Impact factor: 4.402

Review 7.  Renal effects of environmental and occupational lead exposure.

Authors:  M Loghman-Adham
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

8.  Possible influence of delta-aminolevulinic acid dehydratase polymorphism and susceptibility to renal toxicity of lead: a study of a Vietnamese population.

Authors:  Sin Eng Chia; Huijun Zhou; Mei Theng Tham; Eric Yap; Nguyen-Viet Dong; Nguyenthi Hong Tu; Kee Seng Chia
Journal:  Environ Health Perspect       Date:  2005-10       Impact factor: 9.031

9.  Urinary N-acetyl-beta -D-glucosaminidase and its isoenzymes A & B in workers exposed to cadmium at cadmium plating.

Authors:  Ravi Babu Kalahasthi; Hr Rajmohan; Bk Rajan; Karuna Kumar M
Journal:  J Occup Med Toxicol       Date:  2007-07-20       Impact factor: 2.646

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.